Albireo’s rare liver disease drug Bylvay scores back-to-back approvals in U.S., Europe esagonowsky Tue, 07/20/2021 – 17:09 More: Albireo's rare liver disease drug Bylvay scores back-to-back approvals in U.S., Europe Source: fierce
read moreAlexion’s new blockbuster Ultomiris keeps gaining steam as $39B AstraZeneca deal looms fkansteiner Tue, 07/20/2021 – 11:28 More: Alexion's new blockbuster Ultomiris keeps gaining steam as B AstraZeneca deal looms Source: fierce
read moreScandal aside, Biogen’s Aduhelm sales set to reach $1B next year and $6B+ by 2025: analysts nhigginsdunn Tue, 07/20/2021 – 11:23 More: Scandal aside, Biogen's Aduhelm sales set to reach B next year and B+ by 2025: analysts Source: fierce
read moreJohnson & Johnson and 3 distributors ready to settle opioid lawsuits for $26B: report kdunleavy Tue, 07/20/2021 – 10:38 More: Johnson & Johnson and 3 distributors ready to settle opioid lawsuits for B: report Source: fierce
read moreSanofi nets valuable FDA voucher with approval for first oral regimen for neglected sleeping sickness aliu Tue, 07/20/2021 – 10:00 More: Sanofi nets valuable FDA voucher with approval for first oral regimen for neglected sleeping sickness Source: fierce
read moreA therapeutic dose of regdanvimab also reduced the viral load of the SARS-CoV-2 virus and inflammation in the lungs More: Celltrion says its COVID-19 antibody shows ‘strong neutralising activity’ against Delta variant Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals